Char‐Chang Lai

963 citations
14 papers · 823 indexed · h-index 12
Topics
Virus-based gene therapy research (4 papers)T-cell and Retrovirus Studies (3 papers)Cervical Cancer and HPV Research (3 papers)
Partner nations
United States

In The Last Decade

Char‐Chang Lai

14 papers receiving 810 citations

Peers

Char‐Chang Lai
Comparison fields: 5 of 71
  • Molecular Biology 566
  • Immunology 170
  • Oncology 122
  • Epidemiology 108
  • Cell Biology 106
Replace Tomoyuki Miyabayashi with:
Tomoyuki Miyabayashi Japan
Evgenia Leikina United States
Ilse G.L. Pauli Belgium
Concepción Martínez Spain
Junling Jia China
Hiroki Moribe Japan
Laird Bloom United States
Ricardo Villares Spain
Orr Barak United States
Li‐Mei Pai Taiwan
Char‐Chang Lai relative to Tomoyuki Miyabayashi Japan Tomoyuki Miyabayashi's profile →
Citations per field
00.5×3.7×
Tomoyuki Miyabayashi · 1×
Citations per year

Countries citing papers authored by Char‐Chang Lai

Since Specialization
Citations

This map shows the geographic impact of Char‐Chang Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Char‐Chang Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Char‐Chang Lai more than expected).

Fields of papers citing papers by Char‐Chang Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Char‐Chang Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Char‐Chang Lai. The network helps show where Char‐Chang Lai may publish in the future.

Co-authorship network of co-authors of Char‐Chang Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Char‐Chang Lai. A scholar is included among the top collaborators of Char‐Chang Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Char‐Chang Lai. Char‐Chang Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 10
2 102
3 38
4 89
5 2
6 45
7 14
8 30
9 56
10 32
11 86
12 154
13 33
14 132

About Char‐Chang Lai

Char‐Chang Lai is a scholar working on Aging, Immunology and Immunology and Allergy, having authored 14 papers that have together received 823 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), T-cell and Retrovirus Studies (3 papers) and Cervical Cancer and HPV Research (3 papers). The work is most often cited by research in Aging (44 citations), Molecular Biology (566 citations) and Immunology (170 citations). Char‐Chang Lai has collaborated with scholars based in United States. Frequent co-authors include Daniel DiMaio, Mark S. Boguski, Daniel Broek, Scott Powers, Xuejin Zhu, Steven J. Burden, Susan E. Thomas, Ellis L. Reinherz, Bruce B. Reinhold and Weimin Zhong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026